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Summary.-Cell-surface glycoprotein of 3 rat hepatoma strains and late-embryonic
liver was metabolically labelled in vivo with [3H]- or [14C]-fucose. Trypsinization
of the cells and exhaustive pronase digestion of combined hepatoma-liver trypsinates
followed by gel filtration over Sephadex-Biogel mixtures, yielded elutionprofiles that
contained more early-eluting (high-mol.-wt.) glycopeptides for hepatomas than for
liver. At least 3 factors were identified which acted to augment the fraction of early-
eluting tumour glycopeptides: (a) increase of neuraminidase-sensitive sialic acid,
(b) increase of neuraminidase-insensitive sialic acid that was sensitive to mild HCI
hydrolysis, and (c) presence of sugar sulphate groups contributing to a restricted
extent, relative to possible unknown factor(s). Whether (a), (b) or (c) operated
depended on the hepatoma strain or its mode of growth. Notwithstanding these
differences in the nature of the increase in early-eluting glycopeptides, the increase
itself appears not to be due to growth per se, nor to an embryonic expression, but
rather may serve as a marker of tumourigenicity.
THE cell surface seems to be intimately
involved in the establishment offunctional
contact relations between cellswithrespect
to recognition, adhesion and control of
proliferation (Emmelot, 1973; Nicolson,
1976). Since these properties are im-
paired in neoplastic cells it may follow
that surface changes are related to, and
perhaps even be instrumental in neo-
plastic cell behaviour.
Initially, a number of phenomena such
as loss ofahigh-mol.-wt.plasma-membrane
protein (Hynes, 1973), increased con-
canavaliin A agglutination (Burger, 1969),
loss of density-dependent inhibition of
movement and growth (Stoker and Rubin,
1967), decreased growth dependence on
serum concentration (Dulbecco, 1970) and
growth in semi-solid agarose (Stoker and
O'Neill, 1968 seemed to distinguish
between normal and transformed cells.
However, more extended studies have
recently shown that these phenomena are
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not, or are not generally, characteristic of
tumourigenic cells (Kolata, 1975; Shin
et al., 1975; Hynes, 1976; Nicolson, 1976;
Shields, 1976; Smets, Van Beek and Van
Rooij, 1976; Nilsson et al., 1977). These
findings underline the importance of
extending investigations to several cell
systems.
A more promising feature for dis-
tinguishing normal from malignant cells,
in view of its more general occurrence, is
the change recorded in membrane glyco-
peptides, following differential fucose
labelling of normal and tumour cells
(Buck, Glick and Warren, 1970, 1971;
Glick, Rabinowitz and Sachs, 1973, 1974;
Van Beek, Smets and Emmelot, 1973,
1975; Warren et al., 1974; Smets et at.,
1975).
Since most of these experiments were
carried out in vitro it was considered
important to study the change in tumours
grown and labelled in vivo. For in vivoW. P. VAN BEEK, P. EMMELOT AND C. HOMBURG
studies, suitable normal controls are a
matter of concern, since the glycopep-
tides derived from cells of different organs
of the rat exhibit differences in molecular
distribution after gel filtration (unpub-
lished observation). Since Warren,
Zeidman and Buck (1975) lacked the
corresponding in vivo normal cells, they
compared melanomas grown and labelled
in vivo with unrelated normal tissue such
as liver and lung and tissue culture cells.
The present paper reports the results
of the entirely in vivo comparison of three
solid rat hepatomas with late-embryonic
rat liver. The latter tissue is a vital
control in view of the many findings that
tumours, including hepatomas, reacquire
embryonic characters, including cell-
surface antigens (Baldwin, 1973; An-
derson andCoggin, 1976; Fishman andSell,
1976). The use of these tumours in the
present experiments allowed the identi-
fication of at least 3 components that may
increase the apparent molecular weight of
tumour glycopeptides.
MATERIALS AND METHODS
Growth and labelling of cells and tumour8.-
The Novikoff hepatoma strain N15-67 and
Reuber H-35 hepatoma have been obtained
as tissue-culture cell lines from Dr H. Van
Rijn (State University of Utrecht) and
maintained as described previously (Pitot
et al., 1964; Van Beek et al., 1973). For the
present experiments, 5 x 106 Novikoff hepa-
toma cells and 18 x 106 Reuber hepatoma
cells were transferred to the peritoneal
cavity of 3-months-old Sprague-Dawley (SD)
and AXC, female rats, respectively, the
former rats having received 450 rad whole-
body irradiation. The Novikoff hepatoma
yielded tumours that grew as minute
"grapes", palpable within 1 week; this
tumour is designated ST-1. The Reuber
hepatoma also yielded grape-like tumours,
palpable after about 3 weeks.
Another Novikoff hepatoma N151-67
strain was obtained through the courtesy
of Dr E. F. Walborg Jr., The University of
Texas, M.D. Anderson Hospital and Tumor
Institute, at Houston. This tumour was
routinely maintained in the ascites form by
serial passages of 1 ml ascites fluid 8 days
after transplantation. S.c. injection of 0 5
ml of ascites fluid resulted in a solid tumour
nodule (reaching a diameter of 0 5-1 0 cm
in about 2 weeks), referred to as ST-2.
L-[3H]-fucose generally labelled (4.8 Ci/
mmol; New England Nuclear, Boston, Mass.)
was administered by i.p. injection, or directly
into the solid tumours, as soon as tumour
processes became palpable or had reached
the above-mentioned diameter (3 tumour-
bearing rats per experiment). The rats
received 200,uCi, followed after 24 h by
another 100 ,uCi. Pregnant SD females (3
months old) received on Day 18 of their
pregnancy an i.p. injection of 100 ,Ci
L-[1-14C]-fucose (60 mCi/mmol; The Radio-
chemical Centre, Amersham, England),
followed after 24 h by another 50 ,uCi.
Twenty-four hours after the last injection,
the rats were killed and the embryonic livers
collected and washed with N-2-hydroxyethyl
piperazine-N'-2-ethane-sulphonic acid-buffe-
red Hanks' salt solution, pH 7 3 (HHS).
Preparation and chromatography of glyco-
peptides.-Solid hepatomas and liver tissue
were dissociated by careful mincing with
scissors in ice-cold HHS to small pieces of
tissue of about 1-2 mm3. The minced
tissues were washed x 7 by centrifugation at
800 g and resuspension in ice-cold HHS.
Preparations from 5 embryonic livers and
from hepatomas, both corresponding to 3-5 g
wet-weight of tissue, were incubated with
90 ml HHS containing 0.25% trypsin (twice
crystallized, type III; Sigma Chemical Co.,
St. Louis, Mo., U.S.A.) in Erlenmeyer flasks
shaken for 60 min at 60 strokes per min at
35°C.
This method was varied by a stepwise
incubation of the tissue pieces with trypsin-
containing HHS (90 ml total) the tissue
pieces being treated successively with three
30-ml portions of digestion medium for 20
min, followed each time by separation of
liberated cells and medium from the remain-
ing tissue pieces, which were then incubated
with 30 ml fresh digestion medium. The
three 30-ml portions of medium were com-
bined and processed further, the results
being similar to those obtained with the
above-mentioned continuous incubation.
(Mincing of tissue and the second of the
above-mentioned trypsin incubation pro-
cedures under essentially similar conditions
have previously been used to obtain single
cells from solid tumours (Garney and Malm-
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gren, 1967).) In our hands, trypsinization of
the hepatoma tissue pieces tended to damage
the cells, but any intracellular membranes
thus released would not influence the results,
since these membranes of transformed cells
exhibit the same type of glycopeptide change
as does the surface membrane (Warren et al.,
1974, 1975). Moreover, fucose prefereintially
labels surface glycoprotein (Atkinson and
Summers, 1971) and previous experiments
with lymphoblasts (Van Beek et al., 1973)
have shown that "leaking" does not interfere
with the results. The trypsinates thus
obtained were filtered through cheesecloth,
and further processed as described by Van
Beek et al. (1973), including digestion by
pronase (B grade, Calbiochem. A.G., Luzern,
Switzerland) and neuraminidase (from Vibrio
cholerae; Behringwrerke A.G., Marburg/Lahn,
Germany; the enzyme is multispecific towards
the various 0-glycosidically-linked sialyl
bonds).
As an alternative to neuraminidase diges-
tion, lyophilized pronase-digested glycopep-
tides wAere treated with 5 ml O-O1N HCl for
90 min at 80°C. Thereaction was terminated
by cooling to room temperature and neutral-
ization with NaOH, followNed by dialysis
(three-eighths-inch cellulose tubing; A. H.
Thomas Co., Philadelphia, Pa., U.S.A.) at
6°C for 24 h against twice-distilled water.
The non-dialyzable material was lyophilized
and stored at -40°C prior to chromato-
graphy.
The freeze-dried glycopeptide preparation
of the H-35 hepatoma, after mild HCI
hydrolysis, wNas suspended in dry methlanol
containing 0-02M HCl (introduced by
passing dry HCI gas through absolute
methanol), for transesterification of any
sulphate groups present in the glycopeptides
(modified from Kantor and Schubert, 1957).
To remove traces of water, 10 drops of 2,2-
dimethoxypropane (I.C.N. Pharmaceuticals
Inc., New York) were added to the suspension
which w%as then shaken for 5 h at 60°C. The
reaction was stopped by neutralization with
NaOH and cooling to room temperature.
Methanol wNas removed under reduced pres-
sure and the residue wAas solubilized in and
dialyzed against twice-distilled -water for
24 h at 6°C, lyophilized, taken up in the
usual eluent (Van Beek et al., 1973), and
stored at -40°C until chromatography. In
all cases, gel filtration was performed with
1-ml samples on a 2: 1 mixture of Bio-Gel
P10 (200-400 mesh; Bio-Rad Laboratories,
Richmond, California) and Sephadex-G50
fine (Pharmacia, Uppsala, Sweden) as des-
cribed (Van Beek et al., 1973). Experiments
were repeated 3 times with similar
results.
In the elution profile, a vertical shift
indicates a change in amount ofmaterial, and
a horizontal one a change in mol. wt. or size.
A profile is obtained by plotting the percent-
age radioactivity present in each fraction,
wvith the radioactivity of the total eluate
taken as 100. Thus the profiles illustrate
relative amounts of fucose-labelled glyco-
peptides of various molecular weights and,
since the columns w%Nere not overloaded in our
experiments, a profile is-and was checked to
be-independent of the amount of material
brought on the column, and therefore suits
comparative analysis. (For estimated mol.
wts, see Ogata, Muramatsu and Kobata,
1976).
RESULTS
Trypsinization of the hepatoma and
liver cell preparations released 19-30%
of the total amount of labelled fucose
incorporated by the various tissues, in
accord with previous findings on in vitro
labelled cells (Van Beek et al., 1973).
Each of the trypsinates of Novikoff
hepatoma (ST-1 and ST-2) and Reuber
H-35 hepatoma cells, labelled in vivo with
[3H]-fucose, was combined with trypsinate
of late-embryonic rat liver cells, also
labelled in vivo but with [14C]-fucose, and
processe(c with pronase as described in
the Materials and Methods section.
Gel filtration of the final glycopeptides
obtained from each of these 3 pairs of cells
yielded profiles in which the tumour-
derived glycopeptides eluted ahead of the
liver glycopeptides (Figs. IA, 2A and 3A,
Peak II).
The 3 hepatoma glycopeptide pre-
parations were uinequally sensitive to
neuraminidase pretreatment in terms of
their subsequent elution behaviour. In
the case of the Novikoff ST-1 hepatoma,
neuraminidase caused a shift in elution
profile towards lower-mol.-wt (smaller
sized) material (Fig. IB, Peaks II and III
moving into Peaks IV and V) that showed
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FIG. 1. Elution profiles of surface glycopep-
tides from the solid Novikoff rat hepatoma
(ST-1) and late-embryonic rat liver. The
hepatoma was labelled in vivo with [3H]-
fucose (0 *), the liver with [14C]
fucose (0 O). A, pronase-digestedl
glycopeptides; B, following neuraminidase
treatment of A; C, following mild acid
(HCI) hydrolysis of A. BD=bltue dextran
2000.
the same elution profile as the neura-
minidase-pretreated liver glycopeptides.
This coincidence of elution profile
indicated that the original difference in
profiles resulted from an increased density
of neuraminidase-sensitive sialyl groups
in the tumour as compared with the liver
glycopeptides.
However, no such coincidence of
elution profiles of tumour and liver
glycopeptides was obtained after neura-
minidase pretreatment of the 2 other
hepatomas, Novikoff ST-2 (Fig. 2B, Peak
II moving into Peak III, increase of Peak
IV and V) and Reuber H-35 (Fig. 3B, no
effect on tumour glycopeptides). Although
the liver control profiles in Figs. IB and 2B
might suggest an incomplete digestion by
neuraminidase in the experiment of Fig.
2B, other similar experiments confirmed
the difference in neuraminidase-insensitive
sialic acid between ST-1 and ST-2
glycopeptides. Thus, sensitivity to neur-
aminidase, as judged by the shift to lower-
mol.-wt. regions, decreased in the order
Novikoff ST-i > Novikoff ST-2 >
Reuber H-35 hepatomas.
Previously, it has been noted (Emmelot
and Bos, 1972) that about 300o of the
sialic acid of plasma membranes isolated
from solid rat hepatoma (and adult liver)
was insensitive to neuraminidase. Accord-
ingly, the presence of a neuraminidase-
resistant sialic acid fraction might cause,
or contribute to, the lack of effect of
neuraminidase in the last 2 experi-
ments. Therefore, a mild procedure for
removing sialic acid by chemical hydro-
lysis, i.e. 90 min in OO1N HCI at 80°C,
was devised. This procedure is con-
sidered to be specific for sialic acid for the
following reasons: first, of the glycosyl
bonds present in oligo-saccharide moieties,
the sialyl bonds are the ones most sensi-
tive to acid hydrolysis, followed by
fucosyl bonds (Pamer, Glass and Horowitz
1968); and, secondly, at the most only
10% of the fucose label of the present
preparations was lost by the mild HCl
hydrolysis. Its application to the pronase-
digested glycopeptides led to the following
results:
(a) Novikoff ST-I (Fig. IC): The
elution profiles of hepatoma and liver
glycopeptides coincided. However, in
both profiles Peak IV was similarly
decreased and Peak V increased, relative
to the results after neuraminidase pre-
treatment (Fig. IB). These parallel shifts
indicated the additional presence of some
small and about equal amounts of
v
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FIG. 2.-Elution profiles of surface glycopep-
tides from the solid Novikoff rat hepatoma
(ST-2) and late-embryonic rat liver. For
explanation see legend of Fig. 1.
neuraminidase-insensitive, but weak HC1-
sensitive sialic acid in both the hepatoma
and liver glycopeptides.
(b) Novikoff ST-2 (Fig. 2C): The mild
HC1 hydrolysis now led to the coincidence
of tumour and liver elution profiles, which
were similar in shape to those obtained
in the previous experiment of Fig. IC.
This indicated that the original difference
(Fig. 2A) between the Novikoff ST-2 and
liver elution profiles mainly arose from an
increased amount of neuraminidase-insen-
sitive sialic acid in the tumour glycopep-
tides.
(c) Reuber H-35 (Fig. 3C): In this case
the mild HCl hydrolysis had hardly any
effect (this finding adds to the specificity of
the hydrolytic method as argued above)
as judged from the hepatoma elution
profile, emphasizing the difference from
the liver control. Hence in this case
neither neuraminidase- nor weak acid-
sensitive sialic acid (Figs. 3B and 3C,
respectively) appeared to determine the
difference between tumour and liver
elution profiles.
In order to study whether sugar
sulphates might be involved, a very mild
transesterification reaction using dry
methanol (containing 002M HCl), which
should yield methylsulphate into solution,
was carried out on the mild HCl-treated
glycopeptides, as described in Materials
and Methods. As shown in Fig. 3D, the
restricted change obtained in the elution
profile of the tumour, but not of the liver
glycopeptide material, indicated that the
presence of sulphate groups in the tumour
glycopeptide was only to a limited extent
responsible for the difference in elution
profiles. Raising the acid concentration
of the reaction mixture by using 004 or
006M HC1 (the latter as used by Kantor
et al., 1957) resulted in a considerable loss
of the fucose label. As the condition
(0-02M HCI) might have been insufficient
for complete transesterification, more
specific conditions (Usov, Adamyants and
Miroshnikova, 1971; Casu and Gennaro,
1975) are being studied.
DISCUSSION
A change in a cell property that may
differentiate normal from tumour cells-
and thus may be used for detecting
malignancy-should be studied in many
cell systems, different with respect to cell
type, mode of growth, species and onco-
genic determinant, before its general
occurrence can be accepted (Emmelot,
1973; Nicolson, 1976). This approach
U'. 0~~~~~~~~~~~~~~~-
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should be distinguished from the one that
aims at establishing the functional signific-
ance of the phenomenon in molecular
terms. The present paper contributes to
both aspects.
First, the typical shift in the elution
profile demonstrated here for 3 rat
hepatomas relative to late-embryonic rat
liver was obtained with materials that
were differentially labelled in vivo.
Accordingly, the glycopeptide alteration
that is recorded represents a change
in glycoprotein occurring in vivo that
is not due to in vitro conditions such
as have been used in most previous ex-
periments, which might have influenced
the results. It is very well documented
that, in mammals, haemocytoblasts
are invading all the hepatic paren-
chyma during embryonic life. This
haemopoiesis attains its maximal activity
towards 2/3 of the way through gestation,
then regresses rapidly, resulting in a few
disseminated islands of haemopoietic
tissue at birth (Du Bois, 1963). Hardly
any contamination of the latter tissue can
be expected in our experiment using late
embryonic liver as a controlforhepatomas.
Furthermore, regenerating rat liver has
also been used as a control for rat hepa-
toma to the same purpose and with the
same result (Akasaki, Kawasaki and
Yamashina, 1975; Smets et al., 1975).
Thus neither proliferation per se (c.f. also
Van Beek et al., 1975) nor embryonic
expression, is the cause of the altered
surface glycoprotein of the tumour cells.
Instead, this change rather appears to be
intimately associated with the tumori-
genic condition of cells.
Secondly, the experiments demon-
strate the occurrence of at least three
categories of biochemical change that may
underly the increase in the higher-mol.-wt.
tumour glycopeptides.
a. _Neuraminidase-sensitive sialic acid
This acts as the molecular-weight
determinant in most cases of neoplastic
cells which (tend to) grow as single cells or
in suspension, such as transformed cells
in vitro (Warren, Fuhrer and Buck, 1972;
Van Beek et al., 1973), ascites tumour cells
in vivo (the ascites form of Novikoff
hepatoma ST-2): Smets et al., 1975; mouse
lymphosarcoma (MBVIA) and thymus-
derived leukaemic (GRSL) cells: Emmelot,
Van Beek and Smets, 1977) and many
human leukaemias (Van Beek et al., 1975).
In all these cases, pretreatment with
neuraminidase abolishes the difference in
elution profiles between neoplastic and
normal glycopeptides.
In the present study, this category is
represented by the Novikoff hepatoma
ST-I (Fig. lA-C) which grows in the form
of minute "grapes" in the peritoneal
cavity. In this tumour, as in the late-
embryonic liver, intercellular connections
are loose and the tissues are easily dis-
aggregated.
b. N7euraminidase-insensitive sialic acid
sensitive to mild HCl hydrolysis
This markedly contributed to the
molecular-weight increment of the glyco-
peptides obtained from the solid Novikoff
ST-2 hepatoma which was grown as a
single s.c. tumour nodule (Fig. 2A-C).
However, when grown in vitro (Van Beek
et al., 1973) or in ascites form in vivo
(Smets et al., 1975), the glycopeptides of
this tumour become sensitive to neur-
aminidase. Hence it appears that a
change in sialic acid disposition, affecting
the sensitivity to neuraminidase, accom-
panies the solid-ascites interconversion
(c.f. also Cook, Seaman and Weiss, 1963;
Kojima and Maekawa, 1970, 1972). Mode
of growth, rather than tumour type (as
found in other cases, Emmelot et al., 1977)
here determines the sensitivity to
neuraminidase. This phenomenon is not
confined to neoplastic tissues but has also
been observed for regenerating rat liver
when compared with rat liver cells in vitro
(Smets et al., 1975; c.f. also Warren et al.,
1975). Nevertheless, the enrichment in
early-eluting glycopeptides is observed for
ST-2 cells irrespective of a resistance of
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the control material towards neuramini-
dase treatment.
c. Sugar-sulphate ester groups, and un-
knownfactors
In the case of the solid Reuber H-35
hepatoma, the glycopeptides arerefractory
to the action of both neuraminidase and
mild HCI treatment (Fig. 3A-C). These
hepatoma cells, when cultured in vitro and
compared with rat liver cells (Van Beek
et al., 1973), do behave similarly (not
shown) to the solid tumour as described
here. This particular behaviour thus
seems to be tumour-strain-specific. A
similar type ofresistance to neuraminidase
and mild acid hydrolysis has been en-
countered for human chronic myelocytic
leukaemia (Van Beek et al., 1975).
The limited effect of the transesterific-
ation pretreatment (Fig. 3D) seems, within
8
4
2
S CF.
a2
8
6
4
2
I III IV V
II
-
I~D II
I~~~~I
II
-I
~ ~~I
II
I-I
BfD.
I I
II
B I~~~I
II
I~~~~~~~~
20 30 40 50 60 70
the conditions used, to exclude a major
contribution of sulphate groups to the
difference in elution profiles. Hence the
glycopeptides of this category may also
contain an at present unknown molecular-
weight determinant or determinants, or
sialic acid residues with a very specific
disposition which renders them insensitive
to mild acid hydrolysis.
Finally, despite the fact that the
nature of the change causing the increase
in higher-mol-wt. (early-eluting) glyco-
peptides may differ, the finding that the
many tumours studied (summarized by
Emmelot et at., 1977) all show this
increase is unique. To our knowledge it
is the only biochemical parameter that
at the present moment generally dis-
tinguishes cancerous from normal cells.
We wish to thank Dr L. A. Smets for
his help in discussing this work with us.
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FIG. 3.-Elution profile of surface glycopeptides from the solid Reuber H-35 rat hepatoma and
late-embryonic rat liver. For explanation see the legend of Fig. 1; Fig. 3D illustrates the
elution profile ofthe glycopeptides obtained by mild HCI hydrolysis followed by transesterification
as described under Materials and Methods.
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